医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
3期
66-67
,共2页
张延霞%金正贤(通讯作者)%王利群%苏玉文
張延霞%金正賢(通訊作者)%王利群%囌玉文
장연하%금정현(통신작자)%왕리군%소옥문
天麻素%老年人偏头痛%临床疗效
天痳素%老年人偏頭痛%臨床療效
천마소%노년인편두통%림상료효
Gastrodin%elderly migraine%clinical effect
目的:通过观察天麻素治疗老年人偏头痛的临床疗效,了解其临床应用的前景。方法:选择2011.10~2013.10我科收治的老年人偏头痛患者70例,按随机分配原则分为对照组和治疗组各35例,其中治疗组男15例,女20例,年龄60~89岁,平均76.1岁,对照组男13例,女22例,年龄61~88岁,平均75.3岁。两组均给予相同的静脉滴注活血化瘀药物等常规治疗及扩张脑血管、止痛治疗,治疗组在此基础上给予天麻素注射液0.6g加人0.9%氯化钠溶液250 ml静脉滴注。结果:经过治疗后临床疗效比较,治疗组总有效率明显高于对照组(P<0.01)。结论:天麻素注射液治疗老年人偏头痛疗效显著,无明显不良反应,临床中值得推广。
目的:通過觀察天痳素治療老年人偏頭痛的臨床療效,瞭解其臨床應用的前景。方法:選擇2011.10~2013.10我科收治的老年人偏頭痛患者70例,按隨機分配原則分為對照組和治療組各35例,其中治療組男15例,女20例,年齡60~89歲,平均76.1歲,對照組男13例,女22例,年齡61~88歲,平均75.3歲。兩組均給予相同的靜脈滴註活血化瘀藥物等常規治療及擴張腦血管、止痛治療,治療組在此基礎上給予天痳素註射液0.6g加人0.9%氯化鈉溶液250 ml靜脈滴註。結果:經過治療後臨床療效比較,治療組總有效率明顯高于對照組(P<0.01)。結論:天痳素註射液治療老年人偏頭痛療效顯著,無明顯不良反應,臨床中值得推廣。
목적:통과관찰천마소치료노년인편두통적림상료효,료해기림상응용적전경。방법:선택2011.10~2013.10아과수치적노년인편두통환자70례,안수궤분배원칙분위대조조화치료조각35례,기중치료조남15례,녀20례,년령60~89세,평균76.1세,대조조남13례,녀22례,년령61~88세,평균75.3세。량조균급여상동적정맥적주활혈화어약물등상규치료급확장뇌혈관、지통치료,치료조재차기출상급여천마소주사액0.6g가인0.9%록화납용액250 ml정맥적주。결과:경과치료후림상료효비교,치료조총유효솔명현고우대조조(P<0.01)。결론:천마소주사액치료노년인편두통료효현저,무명현불량반응,림상중치득추엄。
Objective To observe the clinical efficacy of Gastrodin in treatment of elderly patients with migraine, to understand the feasibility of clinical application. Methods Choose 2011.10 to 2013.10 in our hospital from 70 cases of elderly patients with migraine, randomly divided into control group and treatment group with 35 cases in each group, the treatment group male 15 cases, female 20 cases, age 60 ~ 89 years old, average age 76.1, contrast group male 13 cases, female 22 cases, age 61 ~ 88 years old, average 75.3 years old. The two groups were given intravenous drip of Huoxue Huayu drugs and other conventional treatment and dilate cerebral vessels, analgesic therapy, the treatment group was given based on Gastrodin Injection 0.6g plus 0.9% Sodium Chloride Solution intravenous infusion of 250 ml. Results Through the comparison of clinical efficacy after treatment, the total effective rate of treatment group was significantly higher than the control group (P<0.01). Conclusion Gastrodin Injection significant efficacy in the treatment of migraine elderly, no obvious adverse reaction, worthy of promotion in clinical therapy.